TGFβ receptor 1: an immune susceptibility gene in HPV-associated cancer.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 25273091)

Published in Cancer Res on October 01, 2014

Authors

Chaya Levovitz1, Dan Chen2, Emma Ivansson2, Ulf Gyllensten2, John P Finnigan3, Sara Alshawish3, Weijia Zhang4, Eric E Schadt5, Marshal R Posner6, Eric M Genden7, Paolo Boffetta8, Andrew G Sikora9

Author Affiliations

1: The Icahn School of Medicine at Mount Sinai, New York, New York. Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York. Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, New York.
2: SciLifeLab Uppsala, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
3: The Icahn School of Medicine at Mount Sinai, New York, New York.
4: Mount Sinai Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
5: Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. Mount Sinai Institute for Genomics and Multiscale Biology, New York, New York.
6: The Icahn School of Medicine at Mount Sinai, New York, New York. Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York.
7: The Icahn School of Medicine at Mount Sinai, New York, New York. Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Immunology, Genetics and Pathology, Tisch Cancer Institute, New York, New York.
8: The Icahn School of Medicine at Mount Sinai, New York, New York. Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Immunology, Genetics and Pathology, Tisch Cancer Institute, New York, New York.
9: The Icahn School of Medicine at Mount Sinai, New York, New York. Department of Immunology, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Otolaryngology-Head and Neck Surgery, Icahn School of Medicine at Mount Sinai, New York, New York. Department of Immunology, Genetics and Pathology, Tisch Cancer Institute, New York, New York. andrew.sikora@bcm.edu.

Associated clinical trials:

M7824 in Subjects With HPV Associated Malignancies | NCT03427411

Articles cited by this

Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52

PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92

Finding the missing heritability of complex diseases. Nature (2009) 67.95

A HapMap harvest of insights into the genetics of common disease. J Clin Invest (2008) 18.31

ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia (2004) 17.08

The mutational landscape of head and neck squamous cell carcinoma. Science (2011) 16.88

Human papillomavirus and cervical cancer. Lancet (2007) 12.47

Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10

Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions. PLoS Genet (2009) 8.39

Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS Genet (2011) 6.20

Validating, augmenting and refining genome-wide association signals. Nat Rev Genet (2009) 4.56

Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer (2009) 4.28

Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis (2011) 2.88

An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity (2011) 2.77

Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer--systematic review and meta-analysis of trends by time and region. Head Neck (2012) 2.40

NEMO and RIP1 control cell fate in response to extensive DNA damage via TNF-α feedforward signaling. Cell (2011) 2.13

The advantages and limitations of trait analysis with GWAS: a review. Plant Methods (2013) 2.08

A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet (2011) 1.68

CRTAM confers late-stage activation of CD8+ T cells to regulate retention within lymph node. J Immunol (2009) 1.57

Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer (2011) 1.41

Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet (2011) 1.39

Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer (2007) 1.39

Loss of TGF-β signaling and PTEN promotes head and neck squamous cell carcinoma through cellular senescence evasion and cancer-related inflammation. Oncogene (2011) 1.38

Heritability of cervical tumours. Int J Cancer (2000) 1.32

Targeting HOX and PBX transcription factors in ovarian cancer. BMC Cancer (2010) 1.29

Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst (2013) 1.22

Regulation of epidermal growth factor receptor signalling by inducible feedback inhibitors. J Cell Sci (2011) 1.17

Epigenetic disruption of two proapoptotic genes MAPK10/JNK3 and PTPN13/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter. Leukemia (2006) 1.12

Risk factors and survival by HPV-16 E6 and E7 antibody status in human papillomavirus positive head and neck cancer. Int J Cancer (2010) 1.12

Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells. Mol Cancer Ther (2011) 1.10

A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet (2013) 1.09

Emerging roles of the EBF family of transcription factors in tumor suppression. Mol Cancer Res (2009) 1.06

Host genes associated with HIV-1 replication in lymphatic tissue. J Immunol (2010) 1.05

Natural killer (NK)-dendritic cell interactions generate MHC class II-dressed NK cells that regulate CD4+ T cells. Proc Natl Acad Sci U S A (2011) 1.04

MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model. Cancer Res (2011) 1.02

Prevalence of high-risk human papillomavirus among older women. Obstet Gynecol (2008) 1.01

Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Br J Cancer (2013) 1.00

Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res (2010) 0.99

Activation of dendritic cells by local ablation of hepatocellular carcinoma. J Hepatol (2005) 0.97

Systems-level analysis of genome-wide association data. G3 (Bethesda) (2013) 0.95

Genome-wide mapping of ZNF652 promoter binding sites in breast cancer cells. J Cell Biochem (2011) 0.93

Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopolysaccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3. J Biol Chem (2011) 0.93

Ischemic time impacts biological integrity of phospho-proteins in PI3K/Akt, Erk/MAPK, and p38 MAPK signaling networks. Anticancer Res (2011) 0.92

GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche. Exp Hematol (2009) 0.92

Integration of biological networks and pathways with genetic association studies. Hum Genet (2012) 0.92

Expression of SNC73, a transcript of the immunoglobulin alpha-1 gene, in human epithelial carcinomas. World J Gastroenterol (2007) 0.91

Transforming growth factor beta1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cells. Cancer Res (2008) 0.90

The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia. Blood (2011) 0.89

Signaling proteins and transcription factors in normal and malignant early B cell development. Bone Marrow Res (2011) 0.89

The modulation of apoptosis by oncogenic viruses. Virol J (2013) 0.89

The lactic acid bacterium Pediococcus acidilactici suppresses autoimmune encephalomyelitis by inducing IL-10-producing regulatory T cells. PLoS One (2011) 0.88

Prevalence, incidence, and recurrence of oral lesions among HIV-infected patients on HAART in Alabama: a two-year longitudinal study. South Med J (2011) 0.88

Role of IL-10 in immune suppression in cervical cancer. Indian J Biochem Biophys (2007) 0.86

Cbl enforces Vav1 dependence and a restricted pathway of T cell development. PLoS One (2011) 0.84

Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy. Oral Oncol (2010) 0.84

TGF-beta signalling pathway factors in HPV-induced cervical lesions. Roum Arch Microbiol Immunol (2011) 0.84

Redundant role for Zap70 in B cell development and activation. Eur J Immunol (2008) 0.83

CRTAM: A molecule involved in epithelial cell adhesion. J Cell Biochem (2010) 0.83

Low-dose, low-dose-rate proton radiation modulates CD4(+) T cell gene expression. Int J Radiat Biol (2009) 0.83

Pathway-based analysis of genetic susceptibility to cervical cancer in situ: HLA-DPB1 affects risk in Swedish women. Genes Immun (2011) 0.83

Genome-wide association study of HPV seropositivity. Hum Mol Genet (2011) 0.82

Myeloid differentiation factor-2 interacts with Lyn kinase and is tyrosine phosphorylated following lipopolysaccharide-induced activation of the TLR4 signaling pathway. J Immunol (2011) 0.82

Genetic variation in the TLR and NF-κB pathways and cervical and vulvar cancer risk: a population-based case-control study. Int J Cancer (2013) 0.81

Expression of HPV16 E5 down-modulates the TGFbeta signaling pathway. Mol Cancer (2013) 0.80

Squamous intraepithelial lesions in HIV-infected women: prevalence, incidence, progression and regression. Arch Gynecol Obstet (2013) 0.79

Immune regulation of the tumor/bone vicious cycle. Ann N Y Acad Sci (2011) 0.79

Characterization of human immunodeficiency virus-1-infected cells of myeloid-monocytic lineage (ML-1, HL-60, THP-1, U-937). J Acquir Immune Defic Syndr (1992) 0.79

Immunocytochemical detection of HoxD9 and Pbx1 homeodomain protein expression in Chinese esophageal squamous cell carcinomas. World J Gastroenterol (2005) 0.79

Mycobacterium bovis BCG and purified protein derivative-induced reduction in the CD80 expression and the antigen up-take function of dendritic cells from patients with cervical cancer. Eur J Obstet Gynecol Reprod Biol (2011) 0.78

Absorption of dihydrotestosterone (DHT) after its intramuscular administration. Fertil Steril (1989) 0.76

Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells. MAbs (2009) 0.76